Novelix Pharmaceuticals Ltd

NSE: TRIMURTHI · BSE: 536565 · Retailing · 31 announcements

Share price: ₹71.95
Market cap: ₹126.7 Cr
Revenue (annual): ₹132.3 Cr
Net profit (annual): ₹2.56 Cr
P/E (TTM): 34.9×Sector 66.8×
Promoter holding: 54.29%+4.86% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 6 Other Announcement 4 Financial Results 4 Annual General Meeting 4 Fund Raise 3 Board Meeting Date 3 Promoter Buying 1 Partnership 1 Management Change 1 Debt & Borrowing 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 Apr 2026 18:20 IST BSE

Debt & Borrowing

Novelix Pharmaceuticals Debt & Borrowing: ₹0.81 Cr

Novelix Pharmaceuticals Limited submitted its initial disclosure under the SEBI Large Corporate framework for FY 2026-27. As of March 31, 2026, the company reported outstanding borrowings of ₹0.81 Crore. The company confirmed it does not meet the criteria to be identified as a Large Corporate for the current financial year.

Value: ₹0.81 Cr

Read the filing ↗